| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Prevalence and risk of progression of light-chain monoclonal gammopathy of undetermined significance: a retrospective population-based cohort study.
|
Lancet
|
2010
|
4.75
|
|
2
|
Cd4+ T-cell immune response to large B-cell non-Hodgkin's lymphoma predicts patient outcome.
|
J Clin Oncol
|
2001
|
2.00
|
|
3
|
CD38 expression levels in chronic lymphocytic leukemia B cells are associated with activation marker expression and differential responses to interferon stimulation.
|
Leukemia
|
2005
|
1.70
|
|
4
|
VEGF receptors on chronic lymphocytic leukemia (CLL) B cells interact with STAT 1 and 3: implication for apoptosis resistance.
|
Leukemia
|
2005
|
1.46
|
|
5
|
T cell-dependent activation of B cell proliferation and differentiation by immobilized monoclonal antibodies to CD3.
|
J Immunol
|
1988
|
1.41
|
|
6
|
Regulation of human B lymphocyte activation, proliferation, and differentiation.
|
Adv Immunol
|
1987
|
1.35
|
|
7
|
Establishment and characterization of three myeloma cell lines that demonstrate variable cytokine responses and abilities to produce autocrine interleukin-6.
|
Leukemia
|
1996
|
1.33
|
|
8
|
B-CLL cells are capable of synthesis and secretion of both pro- and anti-angiogenic molecules.
|
Leukemia
|
2002
|
1.32
|
|
9
|
Inhibition of human B lymphocyte cell cycle progression and differentiation by rapamycin.
|
Cell Immunol
|
1994
|
1.26
|
|
10
|
The roles of interleukin 2 and interferon-gamma in human B cell activation, growth and differentiation.
|
Eur J Immunol
|
1986
|
1.21
|
|
11
|
Human peripheral blood B lymphocyte subpopulations: functional and phenotypic analysis of surface IgD positive and negative subsets.
|
J Immunol
|
1986
|
1.14
|
|
12
|
Nonspecific reactions in the hemagglutination inhibition test for detection of rubella antibodies.
|
J Clin Microbiol
|
1981
|
1.13
|
|
13
|
The effectiveness of double-stranded short inhibitory RNAs (siRNAs) may depend on the method of transfection.
|
Antisense Nucleic Acid Drug Dev
|
2002
|
1.11
|
|
14
|
The role of B cell proliferation in the generation of immunoglobulin-secreting cells in man.
|
J Immunol
|
1983
|
1.09
|
|
15
|
Longitudinal genome-wide analysis of patients with chronic lymphocytic leukemia reveals complex evolution of clonal architecture at disease progression and at the time of relapse.
|
Leukemia
|
2012
|
1.09
|
|
16
|
Evidence for ongoing DNA damage in multiple myeloma cells as revealed by constitutive phosphorylation of H2AX.
|
Leukemia
|
2011
|
1.08
|
|
17
|
Inhibition of human B cell responsiveness by prostaglandin E2.
|
J Immunol
|
1987
|
1.06
|
|
18
|
Phosphatidylinositol 3-kinase activation in normal human B lymphocytes.
|
J Immunol
|
1996
|
1.04
|
|
19
|
Introduction of an activated N-ras oncogene alters the growth characteristics of the interleukin 6-dependent myeloma cell line ANBL6.
|
Cancer Res
|
1995
|
1.04
|
|
20
|
Cloning of the human cholesterol 7 alpha-hydroxylase gene (CYP7) and localization to chromosome 8q11-q12.
|
Genomics
|
1992
|
1.04
|
|
21
|
Interleukin 6 induces monocyte chemoattractant protein-1 expression in myeloma cells.
|
Leukemia
|
2002
|
1.01
|
|
22
|
Regulation of human B cell proliferation by prostaglandin E2.
|
J Immunol
|
1984
|
1.01
|
|
23
|
Immunomodulatory role of IL-4 on the secretion of Ig by human B cells.
|
J Immunol
|
1989
|
1.01
|
|
24
|
Delineation of the functional capacity of human neonatal lymphocytes.
|
J Clin Invest
|
1991
|
1.00
|
|
25
|
Infectious complications among individuals with clinical monoclonal B-cell lymphocytosis (MBL): a cohort study of newly diagnosed cases compared to controls.
|
Leukemia
|
2012
|
0.98
|
|
26
|
CD40 expression in malignant plasma cells. Role in stimulation of autocrine IL-6 secretion by a human myeloma cell line.
|
J Immunol
|
1994
|
0.96
|
|
27
|
Comparative activation requirements of human peripheral blood, spleen, and lymph node B cells.
|
J Immunol
|
1987
|
0.96
|
|
28
|
Inhibition of survivin expression suppresses the growth of aggressive non-Hodgkin's lymphoma.
|
Leukemia
|
2004
|
0.95
|
|
29
|
ZAP-70 is expressed by a subset of normal human B-lymphocytes displaying an activated phenotype.
|
Leukemia
|
2005
|
0.91
|
|
30
|
Increased expression of extracellular matrix metalloproteinase inducer (CD147) in multiple myeloma: role in regulation of myeloma cell proliferation.
|
Leukemia
|
2012
|
0.91
|
|
31
|
The roles of T cell factors in activation, cell cycle progression, and differentiation of human B cells.
|
J Immunol
|
1985
|
0.90
|
|
32
|
Elevation of soluble CD307 (IRTA2/FcRH5) protein in the blood and expression on malignant cells of patients with multiple myeloma, chronic lymphocytic leukemia, and mantle cell lymphoma.
|
Leukemia
|
2006
|
0.89
|
|
33
|
Differential myeloma cell responsiveness to interferon-alpha correlates with differential induction of p19(INK4d) and cyclin D2 expression.
|
J Biol Chem
|
1998
|
0.88
|
|
34
|
Differential activation of a calcium-dependent endonuclease in human B lymphocytes. Role in ionomycin-induced apoptosis.
|
J Immunol
|
1995
|
0.87
|
|
35
|
Regulation of human B cell activation by prostaglandin E2. Suppression of the generation of immunoglobulin-secreting cells.
|
J Clin Invest
|
1985
|
0.86
|
|
36
|
Development of a cell with dendritic morphology from a precursor of B lymphocyte lineage.
|
J Immunol
|
1987
|
0.84
|
|
37
|
Dissociation between IFN-alpha-induced anti-viral and growth signaling pathways.
|
J Immunol
|
1999
|
0.83
|
|
38
|
Expression and function of Fas (APO-1/CD95) in patient myeloma cells and myeloma cell lines.
|
Blood
|
1995
|
0.83
|
|
39
|
Angiogenesis in B-chronic lymphocytic leukemia.
|
Leuk Res
|
2001
|
0.82
|
|
40
|
In vitro autoantibody production by normal adult and cord blood B cells.
|
J Clin Invest
|
1990
|
0.82
|
|
41
|
Analysis of IL-6-mediated growth control of myeloma cells using a gp130 chimeric receptor approach.
|
Leukemia
|
2002
|
0.82
|
|
42
|
Survival of patients with clinically identified monoclonal B-cell lymphocytosis (MBL) relative to the age- and sex-matched general population.
|
Leukemia
|
2011
|
0.81
|
|
43
|
Regulation of human B lymphocyte responsiveness.
|
Scand J Rheumatol Suppl
|
1988
|
0.80
|
|
44
|
Molecular analysis of immunoglobulin genes reveals frequent clonal relatedness in double monoclonal gammopathies.
|
Blood Cancer J
|
2013
|
0.80
|
|
45
|
Genetic characterization of SF3B1 mutations in single chronic lymphocytic leukemia cells.
|
Leukemia
|
2013
|
0.80
|
|
46
|
CLL B cells with a bimodal CD38 expression pattern: persistence of bimodal populations despite effective therapy for B-CLL.
|
Leukemia
|
2004
|
0.78
|
|
47
|
Growth regulatory pathways in myeloma. Evidence for autocrine oncostatin M expression.
|
J Immunol
|
1996
|
0.78
|
|
48
|
A role for phosphatidylinositol 3-kinase in generating T cell help for B cell growth and differentiation.
|
J Immunol
|
1996
|
0.77
|
|
49
|
Dissection of the signalling requirements of interleukin-6-stimulated myeloma cell growth.
|
Acta Oncol
|
2000
|
0.75
|
|
50
|
Angiogenesis in B-chronic lymphocytic leukemia.
|
Leuk Res
|
2001
|
0.75
|
|
51
|
Sequence, expression and function of an mRNA encoding a soluble form of the human interleukin-6 receptor (sIL-6R).
|
Curr Top Microbiol Immunol
|
1995
|
0.75
|
|
52
|
Molecular and biological role of CD40 in multiple myeloma.
|
Curr Top Microbiol Immunol
|
1995
|
0.75
|